WallStreetZen

NYSE: PFE
Pfizer Inc Stock

$39.63-0.52 (-1.30%)
Updated Jun 14, 2021
PFE Price
$39.63
Fair Value Price
N/A
Market Cap
$221.84B
52 Week Low
$31.61
52 Week High
$43.08
P/E
19.91x
P/B
3.23x
P/S
4.56x
PEG
1.23x
Dividend Yield
3.89%
Revenue
$44.46B
Earnings
$11.09B
Gross Margin
76.3%
Operating Margin
26.76%
Profit Margin
24.9%
Debt to Equity
1.31
Operating Cash Flow
$16B
Beta
0.69
Next Earnings
Jul 26, 2021
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
46
Industry average

Reasons for this score

PFE ($39.63) is trading below its intrinsic value of $137.00, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
PFE is good value based on its earnings relative to its share price (19.91x), compared to the US market average 27.51x)
Valuation
PFE is good value based on its earnings relative to its share price (19.91x), compared to the US Drug Manufacturers - General industry average (32.94x)
Valuation

1 of 13

PFE News

Valuation

PFE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
19.91x
Industry
32.94x
Market
27.51x
PFE is good value based on its earnings relative to its share price (19.91x), compared to the US market average 27.51x)
Valuation
PFE is good value based on its earnings relative to its share price (19.91x), compared to the US Drug Manufacturers - General industry average (32.94x)
Valuation

PFE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.23x
Industry
5.41x
PFE is good value based on its book value relative to its share price (3.23x), compared to the US Drug Manufacturers - General industry average (5.41x)
Valuation

PFE price to earnings growth (PEG)

For valuing profitable companies with growth potential
PFE is poor value relative to its rate of earnings growth, measured by PEG ratio (1.23x)
Valuation

PFE's financial health

Profit margin

Revenue
$14.6B
Net Income
$4.9B
Profit Margin
33.4%
PFE's Earnings (EBIT) of $11.90B can safely cover interest payments on company debt ($39.70B)
Financials
PFE's profit margin has decreased (-16.4%) in the last year from (41.3%) to (24.9%)
Financials

Assets to liabilities

Assets
$158.8B
Liabilities
$90.0B
Debt to equity
0.58
PFE's short-term assets ($39.53B) exceed its short-term liabilities ($26.65B)
Financials
PFE's long-term liabilities ($63.30B) exceed its short-term assets ($39.53B)
Financials
PFE's debt relative to shareholder equity (1.31) has decreased or remained constant compared to 5 years ago (1.58)
Financials
PFE's debt to equity ratio (1.31) is considered high
Financials

Cash flow

Operating
$4.5B
Investing
-$1.7B
Financing
-$2.8B
PFE's operating cash flow ($15.81B) is sufficient to service the company's debt ($39.70B)
Financials

Pfizer Stock FAQ

What is Pfizer's quote symbol?

(NYSE: PFE) Pfizer trades on the NYSE under the ticker symbol PFE. Pfizer stock quotes can also be displayed as NYSE: PFE.

What is the 52 week high and low for Pfizer (NYSE: PFE)?

(NYSE: PFE) Pfizer's 52-week high was $43.08, and its 52-week low was $31.61. It is currently -8.01% from its 52-week high and 25.37% from its 52-week low.

How much is Pfizer stock worth today?

(NYSE: PFE) Pfizer currently has 5,597,693,867 outstanding shares. With Pfizer stock trading at $39.63 per share, the total value of Pfizer stock (market capitalization) is $221.84B.

Pfizer stock was originally listed at a price of $24.85 in Dec 31, 1997. If you had invested in Pfizer stock at $24.85, your return over the last 23 years would have been 59.46%, for an annualized return of 2.05%.

How much is Pfizer's stock price per share?

(NYSE: PFE) Pfizer stock price per share is $39.63 today (as of Jun 14, 2021).

What is Pfizer's Market Cap?

(NYSE: PFE) Pfizer's market cap is $221.84B, as of Jun 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pfizer's market cap is calculated by multiplying PFE's current stock price of $39.63 by PFE's total outstanding shares of 5,597,693,867.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.